Savantus Ventures

Siren Biotechnology is a biotech company focused on developing innovative cancer treatments through a unique gene therapy platform. The company merges two advanced therapeutic technologies: adeno-associated virus (AAV) gene therapy and cytokine immunotherapy. This integrated approach addresses significant challenges in cancer treatment, including drug delivery, efficacy, and toxicity. By combining these methods, Siren Biotechnology aims to enhance the elimination of tumor cells and stimulate anti-tumor immune responses, offering a novel strategy for combating cancer.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Enter is a payments platform for the world's leading emerging market businesses.

Chronus Health, Inc. is focused on developing a portable diagnostic platform that delivers rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide real-time diagnoses within minutes. This handheld device significantly enhances the ability of healthcare providers to access actionable data on-site, thereby improving patient outcomes and reducing the time to care. Chronus Health aims to transform the diagnostic process by enabling immediate treatment decisions based on accurate lab results.